Patients et proches > Publications scientifiques

Publications scientifiques

Auteurs
Année
Revue

Found 1071 Results
Page 18 of 18

Newer posts

Are colorectal cancer patients at risk for COVID-19 infection during the postoperative period? The Covid-GRECCAR study

2 mars 2021

A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer

Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT)

Response to the Letter to the editor regarding « Targeting NUPR1 with the small compound ZZW-115 is an efficient strategy to treat hepatocellular carcinoma » by Jiong Lin

Circulating Tumor Cells and Bevacizumab Pharmacokinetics during Neoadjuvant Treatment Combining Chemotherapy and Bevacizumab for Early Breast Cancer: Ancillary Analysis of the AVASTEM Trial

Sphincter-saving surgery for ultra-low rectal carcinoma initially indicated for abdominoperineal resection: Is it safe on a long-term follow-up?

The use of ‘added benefit’ to determine the price of new anti-cancer drugs in France, 2004-2017

Adoptive Cell Therapy in Hepatocellular Carcinoma: Biological Rationale and First Results in Early Phase Clinical Trials

Mastectomy with immediate breast reconstruction: Results of a mono-centric 4-years cohort

Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT)

Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses

A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma

Acute Respiratory Failure Outcomes in Patients with Hematologic Malignancies and Hematopoietic Cell Transplant: A Secondary Analysis of the EFRAIM Study

Validation of a flow cytometry-based method to quantify viable lymphocyte subtypes in fresh and cryopreserved hematopoietic cellular products

Acute Graft-versus-Host-Disease other than typical targets: between myths and facts

Development of an immobilization device for Total Marrow Irradiation

Post-transplantation cyclophosphamide GvHD prophylaxis after hematopoietic stem cell transplantation from 9/10 or 10/10 HLA-matched unrelated donors for acute leukemia

Gene and pathway level analyses of iCOGS variants highlight novel signalling pathways underlying familial breast cancer susceptibility

Hemoglobin overexpression and splice signature as new features of inflammatory breast cancer?

Performance of the ROX index to predict intubation in immunocompromised patients receiving high-flow nasal cannula for acute respiratory failure

First-line treatment of double- and triple-hit lymphomas: Survival and tolerance data from a retrospective multicenter French study

Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance

A gain-of-function RAC2 mutation is associated with bone-marrow hypoplasia and an autosomal dominant form of severe combined immunodeficiency

Phase I Study of Lysine-Specific Demethylase-1 Inhibitor CC-90011 in Patients With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma

Single-cell RNA-seq reveals a concomitant delay in differentiation and cell cycle of aged hematopoietic stem cells

A High-Affinity Peptide Ligand Targeting Syntenin Inhibits Glioblastoma

An international study of interobserver variability of « string sign » of pancreatic cysts among experienced endosonographers

Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets

Total body irradiation + fludarabine compared to busulfan + fludarabine as « reduced-toxicity conditioning » for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT

Kinome rewiring during acquired drug resistance in neuroendocrine neoplasms

Upfront stem cell transplantation for newly diagnosed multiple myeloma with del(17p) and t(4;14): a study from the CMWP-EBMT

The Budding Yeast Life Cycle: more complex than anticipated?

A Personalized Approach to Guide Allogeneic Stem Cell Transplantation in Younger Adults with Acute Myeloid Leukemia

gamma delta T Cell Alterations with Lymph Node Invasion

Toward Therapeutic Targeting of Bone Marrow Leukemic Niche Protective Signals in B-Cell Acute Lymphoblastic Leukemia

Real-life experience with CPX-351 and impact on the outcome of high-risk AML patients: a multicentric French cohort

Outcome beyond third-line chemotherapy for metastatic triple-negative breast cancer in the French ESME program

Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: a French nationwide study

NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response

Efficacy of Circulating Tumor Cell Count-Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: The STIC CTC Randomized Clinical Trial

Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Better leukemia-free survival with allogeneic than with autologous HCT in AML patients with isolated trisomy 8: a study from the ALWP of the EBMT

Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trial

Real-world evidence of cabozantinib in patients with metastatic renal cell carcinoma: Results from the CABOREAL Early Access Program

Association between CD8 and PD-L1 expression and outcomes after radical prostatectomy for localized prostate cancer

1 janvier 2021

Analysis of Recombination at Yeast Telomeres

Impact of body mass index on overall survival in patients with metastatic breast cancer

Laser Treatment (imILT) of Pancreatic Cancer: Safety and Feasibility Results From Two Phase 2a Studies

CRYODESMO-O1: A prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatment

Risk of secondary hematologic malignancies associated with breast cancer chemotherapy and G-CSF support: a nationwide population-based cohort

Impact of early ICU admission for critically ill cancer patients: Post-hoc analysis of a prospective multicenter multinational dataset

Page 18 of 18

Newer posts

Publications scientifiques

Auteurs

Année

Revue